OTCMKTS:WUXAY WuXi AppTec (WUXAY) Stock Price, News & Analysis $4.12 -0.35 (-7.74%) (As of 09/10/2024 05:42 PM ET) Add Compare Share Share Today's Range$4.06▼$4.4750-Day Range$3.52▼$4.6752-Week Range$3.50▼$13.02Volume80,987 shsAverage Volume10,441 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get WuXi AppTec alerts: Email Address Ad Monument Traders AllianceJoin Training: Target 1,000% with One $0.99 election tradeMillionaire Trader Nate Bear is hosting a FREE TRAINING TODAY, where he'll demonstrate how his unique trading strategy can help smart Americans are using to target massive trading profits during the 2024 elections. This is the same trader who famously turned $37k into $2.7 million in just four years, right from his Georgia home.Click here to reserve your free seat >> About WuXi AppTec Stock (OTCMKTS:WUXAY)WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.Read More WUXAY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WUXAY Stock News HeadlinesSeptember 9 at 9:32 PM | msn.comAfter TikTok, China Biotech Next to Face Wrath of US CongressSeptember 9 at 9:32 PM | msn.comUS bill to restrict business with China's WuXi AppTec, BGI passes HouseSeptember 11, 2024 | Timothy Sykes (Ad)“Why I don’t care if the Fed cuts rates” - SYKES In on Friday out by Monday Over the past decade I’ve made millions of dollars with a strategy I call Weekend Trading. It’s the best strategy I know of - because it revolves around making a quick trade right before the market closes on Friday afternoon… And closing the trade when the market opens the following Monday.August 27, 2024 | finance.yahoo.comQ2 2024 update: cell & gene therapy related hiring actvity in the pharma industryAugust 15, 2024 | msn.comHong Kong stocks slip from 2-week high as weak China data outweighs rate optimismAugust 9, 2024 | benzinga.comWuXi AppTec Posts Lower Profits But Avoids More Share Price PainJuly 30, 2024 | marketwatch.comWuXi AppTec Jumps After Chinese Biotech Company Backs 2024 Sales TargetJuly 29, 2024 | msn.comDespite External Challenges, WuXi AppTec Maintained Stable Operations in First Half of 2024; Revenue and Profit of the Second Quarter Both Steadily Improved QoQ as Expected ...September 11, 2024 | Timothy Sykes (Ad)“Why I don’t care if the Fed cuts rates” - SYKES In on Friday out by Monday Over the past decade I’ve made millions of dollars with a strategy I call Weekend Trading. It’s the best strategy I know of - because it revolves around making a quick trade right before the market closes on Friday afternoon… And closing the trade when the market opens the following Monday.July 28, 2024 | markets.businessinsider.comHere's what Wall Street expects from WuXi AppTec's earnings reportJuly 27, 2024 | msn.comThe power struggle between MNCs and nation-StatesMay 29, 2024 | seekingalpha.comHarding Loevner Chinese Equity Composite Q1 2024 ReportMay 15, 2024 | reuters.comUS House committee to vote on bill to restrict BGI, WuXi AppTecMay 14, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Generation Bio (GBIO)May 13, 2024 | msn.comWuXi Shares Volatile as U.S. Bill Revised to Set Deadline for DecouplingMay 10, 2024 | finance.yahoo.comU.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut tiesMay 10, 2024 | reuters.comU.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut tiesApril 29, 2024 | finance.yahoo.comWuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable OperationsSee More Headlines Receive WUXAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:WUXAY CUSIPN/A CIKN/A Webwww.wuxiapptec.com Phone862120663091FaxN/AEmployees41,116Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Ge Li Ph.D. (Age 57)Co-Founder, Chairman, President & CEO Comp: $5.91MDr. Minzhang Chen Ph.D. (Age 55)Co-CEO & Executive Director Comp: $1.54MDr. Qing Yang Ph.D. (Age 55)Co-CEO & Executive Director Comp: $1.07MDr. Edward Hu M.B.A. (Age 62)Vice Chairman, Global Chief Investment Officer, CEO of WuXi ATU & Head of DDSU Comp: $1.18MMs. Ming Shi (Age 50)Senior VP & CFO Mr. Zhaohui Zhang (Age 55)COO of China, Executive VP & Executive Director Comp: $992.35kMr. Yuanzhou Zhang (Age 36)Joint Company Secretary Mr. Ruijia TangIR DirectorDr. Jingchao Dong Ph.D.Senior VP & Head of RCSMr. Tao Guo Ph.D.Senior VP and Head of RCS BD&IPMMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors WUXAY Stock Analysis - Frequently Asked Questions How have WUXAY shares performed this year? WuXi AppTec's stock was trading at $10.1450 at the beginning of 2024. Since then, WUXAY shares have decreased by 59.4% and is now trading at $4.1150. View the best growth stocks for 2024 here. How do I buy shares of WuXi AppTec? Shares of WUXAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:WUXAY) was last updated on 9/11/2024 by MarketBeat.com Staff From Our PartnersFREE TRAINING TODAY ➡️ How to profit from 2024 electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredHow to grow a small trading account into a $100k? Why is Warren Buffett dumping stocks? Billionaires like Warren Buffett, Tim Cook, and Jeff Bezos are offloa...Timothy Sykes | SponsoredKamala's Plan to Bankrupt America—What You Need to KnowWhat if Kamala Wins? The 3 Words That Will Change Everything The same team that predicted Biden’s downfall ...Banyan Hill Publishing | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredIt’s over.We found a tiny company which provides the backbone for the entire $15.7 trillion AI industry... It's used ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi AppTec Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share WuXi AppTec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.